Cresco Labs Inc (CL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 65,993 | 69,304 | 57,725 | 44,949 | 40,019 |
| Income taxes - deferred | 65,854 | -32,659 | -4,643 | -34,931 | -4,447 |
| Accounts receivable | -1,731 | -5,369 | -14,776 | -10,964 | -5,250 |
| Accounts payable and accrued liabilities | -15,539 | 27,795 | 10,700 | 21,155 | -6,529 |
| Other Working Capital | 36,343 | 15,218 | 13,454 | -29,069 | 2,968 |
| Other Operating Activity | -18,440 | -15,725 | -43,719 | 23,347 | -37,592 |
| Operating Cash Flow | $132,480 | $58,564 | $18,741 | $14,487 | $-10,831 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19,060 | -52,791 | -33,790 | -60,718 | -20,573 |
| Net Acquisitions | -3,230 | 0 | -1,135 | -75,745 | -14,768 |
| Purchase Sale Intangibles | -3,994 | -2,498 | -3,106 | -3,178 | -2,105 |
| Other Investing Activity | 1,055 | 10,704 | 1,454 | -24,292 | -6,667 |
| Investing Cash Flow | $-25,229 | $-44,585 | $-36,577 | $-163,933 | $-44,113 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 20,175 | 0 | 387,000 | 186,000 |
| Debt Repayment | -43,784 | -3,485 | -2,426 | -226,250 | -17,893 |
| Common Stock Issued | N/A | N/A | 0 | 124,105 | 3,521 |
| Common Stock Repurchased | -200 | N/A | N/A | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | N/A | -162 |
| Other Financing Activity | -27,494 | -43,597 | -84,217 | -49,850 | -28,792 |
| Financing Cash Flow | $-71,478 | $-26,907 | $-86,643 | $235,005 | $142,674 |
| Exchange Rate Effect | -39 | -62 | -113 | -231 | -1,108 |
| Beginning Cash Position | 108,520 | 121,510 | 226,102 | 140,774 | 54,152 |
| End Cash Position | 144,254 | 108,520 | 121,510 | 226,102 | 140,774 |
| Net Cash Flow | $35,773 | $-12,928 | $-104,479 | $85,559 | $87,730 |
| Free Cash Flow | |||||
| Operating Cash Flow | 132,480 | 58,564 | 18,741 | 14,487 | -10,831 |
| Capital Expenditure | -23,486 | -57,883 | -86,132 | -97,053 | -80,377 |
| Free Cash Flow | 108,994 | 681 | -67,391 | -82,566 | -91,208 |